Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease

Journal of Neuroscience

Volumn 31, Issue 24, 2011, Pages 8986-8997

  Höhn, Sophie ^a,b   Dallérac, Glenn ^a,b   Faure, Alexis ^a,b   Urbach, Yvonne K ^d   Nguyen, Huu Phuc ^c   Riess, Olaf ^c   von Hörsten, Stephan ^d   le Blanc, Pascale ^a,b   Desvignes, Nathalie ^a,b   EL Massioui, Nicole ^a,b   Brown, Bruce L ^e   Doyére, Valerie ^a,b  

^a INSTITUT D'OPTIQUE GRADUATE SCHOOL   (France)

^b CNRS   (France)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; BRAIN DISEASE; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; ELECTRIC POTENTIAL; EVOKED RESPONSE; FACILITATION; FUNCTIONAL ASSESSMENT; HOMOZYGOTE; HUNTINGTON CHOREA; IN VIVO STUDY; LIMBIC CORTEX; LONG TERM POTENTIATION; MALE; MENTAL TASK; MOTOR DYSFUNCTION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NERVOUS SYSTEM PARAMETERS; NONHUMAN; PLASTICITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RNA TUMOR VIRUS; SHORT TERM DEPRESSION; SYMPTOM; WILD TYPE;

ACOUSTIC STIMULATION; AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; GENOTYPE; HUNTINGTON DISEASE; INHIBITION (PSYCHOLOGY); LONGITUDINAL STUDIES; MALE; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; PICROTOXIN; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; STARTLE REACTION; SYNAPTIC MEMBRANES; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 79959349081     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1238-11.2011     Document Type: Article

References (64)

1. Allan LG (2002) The location and interpretation of the bisection point. Q J Exp Psychol B 55:43-60.
2. Antzoulatos EG, Byrne JH (2004) Learning insights transmitted by gluta-mate. Trends Neurosci 27:555-560.
3. Balci F, Day M, Rooney A, Brunner D (2009) Disrupted temporal control in the R6/2 mouse model of Huntington's disease. Behav Neurosci 123:1353-1358.
4. Beste C, Saft C, Andrich J, Müller T, Gold R, Falkenstein M (2007) Time processing in Huntington's disease: a group-control study. PLoS One 2:e1263.
5. Brusilow WS (2006) Is Huntington a glutamine storage disease? Neurosci-entist 12:300-304.
6. Buhusi CV, Meck WH (2005) What make us tick? Functional and neural mechanisms of interval timing. Nat Rev Neurosci 6:755-765.
7. Callu D, El Massioui N, Dutrieux G, Brown BL, Doyere V (2009) Cognitive processing impairments in a supra-second temporal discrimination task in rats with cerebellar lesion. Neurobiol Learn Mem 91:250-259.
8. Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS (2003) Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 23:961-969.
9. Cepeda C, Wu N, André VM, Cummings DM, Levine MS (2007) The cor-ticostriatal pathway in Huntington's disease. Prog Neurobiol 81:253-271.
10. Charpier S, Deniau JM (1997) In vivo activity-dependent plasticity at cortico-striatal connections: evidence for physiological long-term poten-tiation. Proc Natl Acad Sci U S A 94:7036-7040.
11. Charpier S, Mahon S, Deniau JM (1999) In vivo induction of striatal long-term potentiation by low-frequency stimulation of the cerebral cortex. Neuroscience 91:1209-1222.
12. Cheng RK, MacDonald CJ, Meck WH (2006) Differential effects of cocaine and ketamine on time estimation: Implications for neurobiological models of interval timing. Pharmacol Biochem Behav 85:114-122.
13. Cheng RK, Etchegaray M, Meck WH (2007) Impairments in timing, temporal memory, and reversal learning linked to neurotoxic regimens of methamphetamine intoxication. Brain Res 1186:255-266.
14. Church RM, Deluty MZ (1977) Bisection of temporal intervals. J Exp Psy-chol Anim Behav Process 3:216-228.
15. Coull JT, Cheng RK, Meck WH (2011) Neuroanatomical and neurochemi-cal substrates of timing. Neuropsychopharmacology 36:3-25.
16. Crupi D, Ghilardi MF, Mosiello C, Di Rocco A, Quartarone A, Battaglia F (2008) Cortical and brainstem LTP-like plasticity in Huntington's disease. Brain Res Bull 75:107-114.
17. Cummings DM, Milnerwood AJ, Dallerac GM, Waights V, Brown JY, Vat-savayai SC, Hirst MC, Murphy KP (2006) Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Hunting-ton's disease. Hum Mol Genet 15:2856-2868.
18. Cummings DM, Cepeda C, Levine MS (2010) Alterationsinstriatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. ASN Neuro 2:e00036.
19. Dallerac GM, Vatsavayai SC, Cummings DM, Milnerwood AJ, Peddie CJ, Evans KA, Walters SW, Rezaie P, Hirst MC, Murphy KP (2011) Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation. Neu-rodegener Dis 8:230-239.
20. Estrada-Sanchez AM, Montiel T, Segovia J, Massieu L (2009) Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol Dis 34:78-86.
21. Faure A, Hohn S, Von Horsten S, Delatour B, Raber K, Le Blanc P, Desvignes N, Doyere V, El Massioui N (2011) Altered emotional and motivational processing in the transgenic rat model for Huntington's disease. Neuro-biol Learn Mem 95:92-101.
22. Fitch RH, Threlkeld SW, McClure MM, Peiffer AM (2008) Use of a modified prepulse inhibition paradigm to assess complex auditory discrimination in rodents. Brain Res Bull 76:1-7.
23. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, Con-neally PM, Christian JC (1995) Cognitive scores in carriers of Hunting-ton's disease gene compared to noncarriers. Ann Neurol 37:657-664.
24. Gabbott PL, Warner TA, Jays PR, Salway P, Busby SJ (2005) Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 492:145-177.
25. Gerfen CR (1984) The neostriatal mosaic: compartmentalization ofcortico-striatal input and striatonigral output systems. Nature 311:461-464.
26. Grondin S (2001) Discriminating time intervals presented in sequences marked by visuals signals. Percept Psychophys 63:1214-1228.
27. Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM (2007) Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13:539-543.
28. Kántor O, Temel Y, Holzmann C, Raber K, Nguyen HP, Cao C, Turkoglu HO, Rutten BP, Visser-Vandewalle V, Steinbusch HW, Blokland A, Korr H, Riess O, von Horsten S, Schmitz C (2006) Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiol Dis 22:538-547.
29. Karl T, Pabst R, von Hörsten S (2003) Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55:69-83.
30. Killeen PR, Fetterman JG, Bizo LA (1997) Time's causes. In: Time and behavior: psychological and neurological analyses (Bradshaw CM, Szabadi E, eds), pp 79-131. Amsterdam: Elsevier Science.
31. Kung VW, Hassam R, Morton AJ, Jones S (2007) Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease. Neuroscience 146:1571-1580.
32. Lawrence AD, Sahakian BJ, Hodges JR, Rosser AE, Lange KW, Robbins TW (1996) Executive and mnemonic functions in early Huntington's disease. Brain 119:1633-1645.
33. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, ffrench-Constant C, Ru-binsztein DC, Robbins TW, Sahakian BJ (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121:1329-1341.
34. Maricq AV, Church RM (1983) The differential effects of haloperidol and methamphetamine on time estimation in the rat. Psychopharmacology 79:10-15.
35. Maricq AV, Roberts S, Church RM (1981) Methamphetamine and time estimation. J Exp Psychol Anim Behav Process 7:18-30.
36. Matell MS, Bateson M, Meck WH (2006) Single-trials analyses demonstrate that increases in clock speed contribute to the methamphetamine-induced horizontal shifts in peak-interval timing functions. Psychophar-macology 188:201-212.
37. Meck WH (1983) Selective adjustment of the speed of internal clock and memory processes. J Exp Psychol Anim Behav Process 9:171-201.
38. MeckWH (2006) Neuroanatomical localizationof an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopami-nergic systems. Brain Res 1109:93-107.
39. Miller BR, Walker AG, Fowler SC, von Hörsten S, Riess O, Johnson MA, Rebec GV (2010) Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease. Neurobiol Dis 37:106-113.
40. Miller BR, Walker AG, Shah AS, Barton SJ, Rebec GV (2008) Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease. J Neurophysiol 100:2205-2216.
41. Milnerwood AJ, Raymond LA (2007) Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeats length and protein load. J Physiol 585:817-831.
42. Milnerwood AJ, Cummings DM, Dallerac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet 15:1690-1703.
43. Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA (2010) Early increases in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron 65:178-190.
44. Nguyen HP, Kobbe P, Rahne H, Worpel T, Jager B, Stephan M, Pabst R, Holzmann C, Riess O, Korr H, Kantor O, Petrasch-Parwez E, Wetzel R, Osmand A, von Hörsten S (2006) Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 15:3177-3194.
45. Olney JW, Zorumski CF, Stewart GR, Price MT, Wang GJ, Labruyere J (1990) ExitotoxicityofL-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases. Exp Neurol 108:269-272.
46. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, Reynolds NC, Rao SM (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am J Neuroradiol 25:1715-1721.
47. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, Guttman M, Johnson S, MacDonald M, Beglinger LJ, Duff K, Kayson E, Biglan K, Shoulson I, Oakes D, Hayden M; Predict-HD Investigators and Coordinators of the Huntington Study Group (2008) Detection of Hunting-ton's disease decades before diagnosis: the predict-HD study. J Neurol Neurosurg Psychiatry 79:874-880.
48. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. San Diego: Academic.
49. Penney TB, Gibbon J, Meck WH (2008) Categorical scaling of duration bisection in pigeons (Colulmbia livia), mice (Mus musculus), and humans (Homo sapiens). Psychol Sci 19:1103-1109.
50. Rammsayer TH (1999) Neuropharmacological evidence for different timing mechanisms in humans. Q J Exp Psychol B 52:273-286.
51. Rouanet H, Bernard J-M, Le Roux B (1990) Analyse inductive des données. In: Statistique en sciences humaines. Paris: Dunod.
52. Rowe KC, Paulsen JS, Langbehn DR, Duff K, Beglinger LJ, Wang C, O'Rourke JJ, Stout JC, Moser DJ (2010) Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology 24:435-442.
53. Stubbs A (1968) The discrimination of stimulus duration by pigeons. J Exp Anal Behav 11:223-238.
54. Urbach YK, Bode FJ, Nguyen HP, Riess O, von Horsten S (2010) Neurobe-havioral tests in rat models of degenerative brain diseases. Methods Mol Biol 597:333-356.
55. von Horsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O (2003) Transgenic rat model for Huntington's disease. Hum Mol Genet 12:617-624.
56. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neu-ropathol Exp Neurol 44:559-577.
57. Walker AG, Miller BR, Fritsch JN, Barton SJ, Rebec GV (2008) Altered information processing in the prefrontal cortex of Huntington's disease mouse models. J Neurosci 28:8973-8982.
58. Wilson RS, Como PG, Garron DC, Klawans HL, Barr A, Klawans D (1987) Memory failure in Huntington's disease. J Clin Exp Neuropsychol 9:147-154.
59. Woodruff-Pak DS, Papka M (1996) Huntington's disease and eyeblink classical conditioning: normal learning but abnormal timing. J Int Neuropsy-chol Soc 2:323-334.
60. Zeron MM, Chen N, Moshaver A, Lee AT, Wellington CL, Hayden MR, RaymondLA (2001) Mutant huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 17:41-53.
61. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA (2002) Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicityin a mouse modelofHunting-ton's disease. Neuron 33:849-860.
62. Zeron MM, Fernandes HB, Krebs C, Shehadeh J, Wellington CL, Leavitt BR, Baimbridge KG, Hayden MR, Raymond LA (2004) Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol Cell Neurosci 25:469-479.
63. Zucker RS (1973) Changes in the statistics of transmitter release during facilitation. J Physiol 229:787-810.
64. Zucker RS, Regehr WG (2002) Short-term plasticity. Annu Rev Physiol 64: 355-405.